Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Other
  • New NIHR-funded TRC for Parkinson’s disease
  • Other

New NIHR-funded TRC for Parkinson’s disease

Pharmaphorum

The launch of a new national research collaboration focused on Parkinson's disease has been announced.

Neuroscience

Read full story

pharminent April 27, 2026 (Last updated: April 27, 2026)

Pharmaphorum

The launch of a new national research collaboration focused on Parkinson’s disease has been announced.

Neuroscience

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Lilly falls on slower start for Foundayo versus Wegovy
Next: Novartis secures pair of regulatory wins for skin disease and malaria treatments

Related Stories

  • Other

ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer

pharminent June 2, 2026
  • Other

ASCO26: Symptom-tracking app helps advanced cancer patients

pharminent June 2, 2026
  • Other

All eyes on Revolution, bispecific antibodies and more at ASCO26

pharminent May 26, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.